Portfolio

Vessi Medical

A new ablative approach for the treatment of urological tissue

Technology Development

Business Development

Revenue

Exited

Founded

2017

CEO
Eyal Kochavi
UN SDGs
3
Contact Us
email email
Follow Us
linkedin
Investors
The Trendlines Group ; the Israel Innovation Authority, Agriline (CBG), ALIVE VC

About

Vessi Medical has developed a new ablative approach for the treatment of urological tissue. The Company uses surface cryotherapy, a treatment that utilizes extreme cold, to freeze and destroy abnormal tissue. Its minimally invasive solution provides an office-based therapeutic alternative to surgery.

Currently, surface cryotherapy is used extensively in many applications, and it has been known to be highly effective in destroying surface lesions.

The Vessi Medical system consists of a standalone console and a disposable catheter that is inserted into the bladder similar to existing intravesical (inside the bladder) techniques.

Market Need

The markets seeks an effective ablative treatment of urological tissue that offers reduced side effects, improved patient outcomes, and lower healthcare costs.

Skip to content